279 related articles for article (PubMed ID: 26222560)
21. CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function.
Pires C; Marques IJ; Valério M; Saramago A; Santo PE; Santos S; Silva M; Moura MM; Matos J; Pereira T; Cabrera R; Lousa D; Leite V; Bandeiras TM; Vicente JB; Cavaco BM
J Biol Chem; 2024 Mar; 300(3):105767. PubMed ID: 38367672
[TBL] [Abstract][Full Text] [Related]
22. Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.
Cirello V; Colombo C; Karapanou O; Pogliaghi G; Persani L; Fugazzola L
Front Endocrinol (Lausanne); 2020; 11():589340. PubMed ID: 33488516
[TBL] [Abstract][Full Text] [Related]
23. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer.
Xing M
Clin Endocrinol (Oxf); 2005 Sep; 63(3):263-6. PubMed ID: 16117812
[TBL] [Abstract][Full Text] [Related]
24. Thyroid cancer genetics: multiple endocrine neoplasia type 2, non-medullary familial thyroid cancer, and familial syndromes associated with thyroid cancer.
Richards ML
Surg Oncol Clin N Am; 2009 Jan; 18(1):39-52, viii. PubMed ID: 19056041
[TBL] [Abstract][Full Text] [Related]
25. The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in Hispanics.
Bohórquez ME; Estrada AP; Stultz J; Sahasrabudhe R; Williamson J; Lott P; Duque CS; Donado J; Mateus G; Bolaños F; Vélez A; Echeverry M; Carvajal-Carmona LG
Endocr Connect; 2016 May; 5(3):123-7. PubMed ID: 27097599
[TBL] [Abstract][Full Text] [Related]
26. BROX haploinsufficiency in familial nonmedullary thyroid cancer.
Pasquali D; Torella A; Accardo G; Esposito D; Del Vecchio Blanco F; Salvatore D; Sabatino P; Pacini F; Barbato F; Castagna MG; Cantara S; Nigro V
J Endocrinol Invest; 2021 Jan; 44(1):165-171. PubMed ID: 32385852
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1.
Bevan S; Pal T; Greenberg CR; Green H; Wixey J; Bignell G; Narod SA; Foulkes WD; Stratton MR; Houlston RS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3701-4. PubMed ID: 11502798
[TBL] [Abstract][Full Text] [Related]
28. HABP2 in Familial Non-medullary Thyroid Cancer: Will the Real Mutation Please Stand Up?
Ngeow J; Eng C
J Natl Cancer Inst; 2016 Jun; 108(6):djw013. PubMed ID: 26832774
[No Abstract] [Full Text] [Related]
29. Genetic predisposition for nonmedullary thyroid cancer.
Nagy R; Ringel MD
Horm Cancer; 2015 Feb; 6(1):13-20. PubMed ID: 25338077
[TBL] [Abstract][Full Text] [Related]
30. A Germline
Zhao Y; Yu T; Chen L; Xie D; Wang F; Fu L; Cheng C; Li Y; Zhu X; Miao G
Thyroid; 2020 Jun; 30(6):924-930. PubMed ID: 32041497
[TBL] [Abstract][Full Text] [Related]
31. Familial nonmedullary thyroid neoplasia.
Rubén Harach H
Endocr Pathol; 2001; 12(2):97-112. PubMed ID: 11579685
[TBL] [Abstract][Full Text] [Related]
32. Identification of
Marques IJ; Gomes I; Pojo M; Pires C; Moura MM; Cabrera R; Santos C; van IJcken WFJ; Teixeira MR; Ramalho JS; Leite V; Cavaco BM
Thyroid; 2021 Sep; 31(9):1366-1375. PubMed ID: 33906393
[No Abstract] [Full Text] [Related]
33. Hereditary non-medullary thyroid cancer.
Kebebew E
World J Surg; 2008 May; 32(5):678-82. PubMed ID: 18058169
[TBL] [Abstract][Full Text] [Related]
34. Multigenerational familial medullary thyroid cancer (FMTC): evidence for FMTC phenocopies and association with papillary thyroid cancer.
Fugazzola L; Cerutti N; Mannavola D; Ghilardi G; Alberti L; Romoli R; Beck-Peccoz P
Clin Endocrinol (Oxf); 2002 Jan; 56(1):53-63. PubMed ID: 11849247
[TBL] [Abstract][Full Text] [Related]
35. Functional Common and Rare
Bao R; Ng A; Sasaki M; Esai Selvan M; Katti A; Lee H; Huang L; Skol AD; Lavarino C; Salvador H; Klein RJ; Gümüş ZH; Mora J; Onel K
Cancer Prev Res (Phila); 2021 Apr; 14(4):441-454. PubMed ID: 33419763
[TBL] [Abstract][Full Text] [Related]
36. Familial non-medullary thyroid cancer: unraveling the genetic maze.
Peiling Yang S; Ngeow J
Endocr Relat Cancer; 2016 Dec; 23(12):R577-R595. PubMed ID: 27807061
[TBL] [Abstract][Full Text] [Related]
37. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer.
Vriens MR; Suh I; Moses W; Kebebew E
Thyroid; 2009 Dec; 19(12):1343-9. PubMed ID: 20001717
[TBL] [Abstract][Full Text] [Related]
38.
Orois A; Gara SK; Mora M; Halperin I; Martínez S; Alfayate R; Kebebew E; Oriola J
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31703244
[TBL] [Abstract][Full Text] [Related]
39. Family with nonmedullary thyroid neoplasms.
Kobayashi K; Tanaka Y; Ishiguro S; Mori T; Mitani Y; Shigemasa C
J Surg Oncol; 1995 Apr; 58(4):274-7. PubMed ID: 7723373
[TBL] [Abstract][Full Text] [Related]
40. The p.G534E variant of
Kowalik A; Gąsior-Perczak D; Gromek M; Siołek M; Walczyk A; Pałyga I; Chłopek M; Kopczyński J; Mężyk R; Kowalska A; Góźdź S
Oncotarget; 2017 Aug; 8(35):58304-58308. PubMed ID: 28938557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]